0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Aberrant ossification halted after head trauma

Catherine Macek
JAMA. 1983;249(8):993. doi:10.1001/jama.1983.03330320007003.
Text Size: A A A
Published online

ABSTRACT

One of the many complications of severe head trauma is heterotopic ossification (HO), the formation in various parts of the body of new bony masses in tissue (such as muscle) that usually does not calcify. Prophylactic treatments such as active and passive motion, splinting, anti-inflammatory drugs, diathermy, ultrasound, and low-dose radiation all have had limited success in preventing such ossification.

The results of two preliminary studies, however, indicate that etidronate disodium, an agent most commonly used to treat Paget's disease, has proved useful in preventing primary HO as well as its recurrence after surgical removal of aberrant bony masses.

Etidronate and other diphosphonates are analogues of pyrophosphate, which is involved with calcification in vivo. Diphosphonates apparently retard both the formation and dissolution of hydroxyapatite crystals, thereby preventing bone resorption (as occurs in Paget's disease) as well as ectopic soft tissue calcification.

Although diphosphonates have been used to prevent HO in

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();